UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry.
about
Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic InsultRule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats.A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMSUrinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS.Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosisUrinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia.Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.Bioanalytical techniques in nontargeted clinical lipidomics.Metabonomic biomarkers for risk factors of chronic kidney disease.Acute nephrotoxicity of aristolochic acid in vitro: metabolomics study for intracellular metabolic time-course changes.Metabolic mapping of Schisandra sphenanthera extract and its active lignans using a metabolomic approach based on ultra high performance liquid chromatography with high-resolution mass spectrometry.Lessons learned from metabolomics in cystic fibrosis.Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease.The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.New perspectives on CKD-induced dyslipidemia.Application of ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry in identification of three isoflavone glycosides and their corresponding metabolites.Identification of metabolites of palmatine in rats after oral administration using ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.Chytridiomycosis causes catastrophic organism-wide metabolic dysregulation including profound failure of cellular energy pathways.Biomarcadores de função endotelial em doenças cardiovasculares: hipertensão.Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney DiseaseMetabolomics Analysis of the Lipid-Regulating Effect of in a Hamster Model of High-Fat Diet-Induced Hyperlipidemia by UPLC/ESI-Q-TOF Mass Spectrometry
P2860
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
P2860
UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
UPLC-based metabonomic applica ...... iseases in clinical chemistry.
@ast
UPLC-based metabonomic applica ...... iseases in clinical chemistry.
@en
type
label
UPLC-based metabonomic applica ...... iseases in clinical chemistry.
@ast
UPLC-based metabonomic applica ...... iseases in clinical chemistry.
@en
prefLabel
UPLC-based metabonomic applica ...... iseases in clinical chemistry.
@ast
UPLC-based metabonomic applica ...... iseases in clinical chemistry.
@en
P2093
P1476
UPLC-based metabonomic applica ...... iseases in clinical chemistry.
@en
P2093
Nosratola D Vaziri
Rui-Chao Lin
Shuman Liu
Xian-Long Cheng
P356
10.1016/J.CLINBIOCHEM.2014.07.019
P577
2014-08-01T00:00:00Z